Søren Jacobsen

Research interests

Publications

• 2021 DORIS definition of remission in SLE: final recommendations from an international task force

  Lupus Science & Medicine · 2021 · https://doi.org/10.1136/lupus-2021-000538

• 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

  Arthritis & Rheumatology · 2019 · https://doi.org/10.1002/art.40930

• 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2018-214819

• Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial

  Journal of Alzheimer s Disease · 2016 · https://doi.org/10.3233/jad-150817

• A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209519

• The frequency and outcome of lupus nephritis: results from an international inception cohort study

  Lara D. Veeken · 2015 · https://doi.org/10.1093/rheumatology/kev311

• Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-205139

• Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-204838

• Cancer risk in systemic lupus: An updated international multi-centre cohort study

  Journal of Autoimmunity · 2013 · https://doi.org/10.1016/j.jaut.2012.12.009

• Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

  Arthritis & Rheumatism · 2012 · https://doi.org/10.1002/art.34473

• MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

  Annals of the Rheumatic Diseases · 2008 · https://doi.org/10.1136/ard.2008.088245

• Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

  Arthritis & Rheumatism · 2002 · https://doi.org/10.1002/art.10187

Current projects

No projects listed.